IndiaTickerOmkar Pharmachem Ltd - 532167 - Newspaper Publication Regarding Special WindowBSE · exchange filing · pdf
Source filing Company dossier
Omkar Pharmachem
BSE:OMKARPH · ISIN INE501C01015
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Omkar Pharmachem
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 30 May, 2026BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Financial Results For The Quarter And Year Ended 31.03.2026BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2026BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Change In Name Of Managing Director Of The CompanyBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Newspaper Publication Regarding Special Window For Transfer And Dematerialization (Demat) Of Physical SharesBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Newspaper Publication Regarding Special Window For Transfer And Dematerialization (Demat) Of Physical SharesBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February, 2026BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests From 01St January, 2026 To 06Th January 2026BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Re-Lodgment Of Transfer Requests For The Months Of October And November 2025BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Results- Unaudited Financial Results For September, 2025BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Board Meeting Intimation For Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Half Yearly Ended September 30, 2025BSE · financial results · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests For The Month Of September, 2025BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Omkar Pharmachem Ltd - 532167 - 30Th AGM Scheduled To Be Held On 24Th Day Of September, 2025BSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Corporate Action-Fixes Record Date For 30Th AGMBSE · exchange filing · pdf
Source filing Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing